Posted inCardiagtech
Neoadjuvant FOLFIRINOX in Borderline/Locally Advanced Pancreatic Cancer: A 269/4 Analysis
Neoadjuvant chemotherapy, often with the FOLFIRINOX regimen (269/4), has become a cornerstone in the management of borderline resectable…